KBIO COMPANY Inc.

A038530

KR7038530002

Drug Retailers

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
267 ^KRW	-1.11%		0.00%	-4.98%

2023	Gold Pacific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	INCON Co.,Ltd. announced that it has received KRW 10 billion in funding from Gold Pacific Co., Ltd.	CI

Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding

January 21, 2021

On January 22, 2021, Gold Pacific Co., Ltd. (KOSDAQ:A038530) closed the transaction.. The conversion of bonds will start on January 22, 2022 and end on December 22, 2023. The maturity date of bonds has changed to January 22, 2024.

Latest news about KBIO COMPANY Inc.

Gold Pacific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
INCON Co.,Ltd. announced that it has received KRW 10 billion in funding from Gold Pacific Co., Ltd.	22-11-09	CI
Gold Pacific Co., Ltd. announced that it has received KRW 10.1 billion in funding	21-11-23	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Ellim Corporation Co., Ltd. and other investors	21-10-18	CI
Gold Pacific Co., Ltd. agreed to acquire Distribution Business of CureBio Co.,Ltd. for KRW 6.5 billion.	21-08-31	CI
Gold Pacific Co., Ltd. announced that it has received KRW 8.001 billion in funding from Elim Corporation	21-04-08	CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding	21-01-21	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding	21-01-18	CI
Arthur Mine Fund and Flare Fund acquired 9.6% stake in Jokwang ILI Co., Ltd. from Gold Pacific Co., Ltd. for KRW 9.7 billion.	20-11-09	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10.000084 billion in funding from Elim Corporation	20-10-11	CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd	20-09-16	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd	20-09-07	CI
Gold Pacific Co., Ltd. cancelled the acquisition of an additional 16.4% stake in Incon Co., Ltd. from H.Anderson Co., Ltd.	20-07-28	CI
Gold Pacific Co., Ltd. announced that it has received KRW 6 billion in funding	20-06-11	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding	20-03-23	CI
Kim Woo-dong, Gold Pacific Co., Ltd. and two others completed the acquisition of 41.33% stake in Jokwang ILI Co., Ltd. from Lim Man-soo and five others.	19-11-13	CI
Cornerstone Networks CO., LTD announced that it has received KRW 1.5 billion in funding from Gold Pacific Co., Ltd.	19-11-11	CI
Kim Woo-dong, Gold Pacific Co., Ltd. and two others entered into an agreement to acquire 41.33% stake in Jokwang ILI Co., Ltd. from Lim Man-soo and five others for KRW 40.9 billion.	19-10-13	CI
Incon Co., Ltd. announced that it has received KRW 9 billion in funding from River Stone Co., Ltd., Gold Pacific Co., Ltd.	19-07-28	CI
Gold Pacific Co., Ltd. entered into an agreement to acquire an additional 16.4% stake in Incon Co., Ltd. from H.Anderson Co., Ltd. for KRW 44.2 billion.	19-07-28	CI
Gold Pacific Co., Ltd. completed the acquisition of Danaun Co., Ltd.	19-06-30	CI
Gold Pacific Co., Ltd. announced that it has received KRW 3.5 billion in funding	19-06-30	CI
Gold Pacific Co., Ltd. entered into an agreement to acquire Danaun Co., Ltd. for KRW 10.5 billion.	19-06-20	CI
An unknown buyer cancelled the acquisition of 6.1% stake in PangSky Co., Ltd. from Gold Pacific Co., Ltd..	19-06-19	CI
Incon Co., Ltd. announced that it expects to receive KRW 10.00000084 billion in funding from River Stone Co., Ltd., Gold Pacific Co., Ltd.	19-05-22	CI

Chart KBIO COMPANY Inc.

Duration

Period

More charts

Company Profile

KBio Company Inc, formerly Gold Pacific Co Ltd, is a Korea-based company primarily engaged in the bio distribution business. The Company operates its business through three segments. The Bio Distribution segment is engaged in the supply of research reagents and consumables to each customer through hospitals, universities, research institutes, and dealers. The Fashion segment is engaged in the production and sale of products such as handmade leather goods, clothing, and accessories. The Other segment is engaged in the fashion promotion business and other businesses.

Sector

Drug Retailers

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
KBIO COMPANY INC.	-4.98%	22.4M
WALGREENS BOOTS ALLIANCE, INC.	-32.21%	15.27B
JD HEALTH INTERNATIONAL INC.	-31.97%	10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-30.42%	6.06B
YIFENG PHARMACY CHAIN CO., LTD.	+8.14%	6.04B
MATSUKIYOCOCOKARA & CO.	-11.41%	5.86B
NAHDI MEDICAL COMPANY	-0.88%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.19%	4.29B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.86%	3.33B
WELCIA HOLDINGS CO., LTD.	-6.93%	3.01B